- Home
-
Regulatory functions
- Corporates
- Intermediaries
-
Products
- List of publicly offered investment products
- List of ESG funds
- Open-ended fund companies
- Real estate investment trusts
- Grant Scheme for Open-ended Fund Companies and Real Estate Investment Trusts
- Circulars
- Consultations and conclusions
- Forms & checklists
- FAQs
- List of Eligible Collective Investment Schemes under the New Capital Investment Entrant Scheme (New CIES)
- Quick Reference to FASTrack Applications
- Markets
- Enforcement
-
Corporates
- Dual filing
- Corporate disclosure
-
Takeovers and mergers
- Dealing disclosures
- Decisions and statements
- Disciplinary proceedings
- Documents on display
- Exempt status
- Offer periods
- Practice notes
- Performance Pledges
- Post-vet list
- Secondary listed companies
- Takeovers Panel and related committees
- Transaction announcements and documents
- Takeovers Bulletin
- Forms
- Consultations and Conclusions
- Unlisted shares, debentures
- Circulars
- Consultations and conclusions
- FAQs
-
Takeovers and mergers
- Dealing disclosures
- Decisions and statements
- Disciplinary proceedings
- Documents on display
- Exempt status
- Offer periods
- Practice notes
- Performance Pledges
- Post-vet list
- Secondary listed companies
- Takeovers Panel and related committees
- Transaction announcements and documents
- Takeovers Bulletin
- Forms
- Consultations and Conclusions
- Dealing disclosures
- Past transaction
Past transaction
China Biotech Services Holdings Limited
Dealing disclosure of current transactions (from 31/05/2014)
| Date of Submission | Date of Dealing | Party Dealing | Capacity | Type of Dealing |
|---|---|---|---|---|
| 19 May 2016 | 16 May 2016 | China Wah Yan Healthcare Limited | the Offeror | Dealings in ordinary shares |
Last update: 15 Nov 2024